Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04947865 · ClinicalTrials.gov registry record · NA
Reflex Excitability in Post-stroke Stiff-Knee Gait
A NA study of Stroke and Chronic Stroke, sponsored by MetroHealth Medical Center.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT04947865: Active NA study of Stroke and Chronic Stroke, sponsored by MetroHealth Medical Center.
NCT04947865 is a NA study of Stroke and Chronic Stroke that is active but no longer recruiting, run by MetroHealth Medical Center. The registered enrollment target is 60 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04947865, a NA study of Stroke and Chronic Stroke, is active but no longer recruiting, sponsored by MetroHealth Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the reflex excitability of the rectus femoris in individuals with and without post-stroke Stiff-Knee gait. We use electrical stimulation of the peripheral nerve innervating the rectus femoris for a well-controlled reflex stimulus. We are investigating whether reflex excitability of the rectus femoris correlates with gait kinematics.
Primary Outcome
Recording electrical activity of leg muscles during walking in response to peripheral nerve stimulation
Conditions Studied
Interventions
- OTHER Peripheral nerve stimulation
- DEVICE Commercial knee brace
Study Locations (1)
Ohio
- MetroHealth Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-06-11 |
| Est. Completion | 2026-06-11 |
| Phase | NA |
What the registry record for NCT04947865 still lists
NCT04947865 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 7 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Peripheral nerve stimulation is the first listed.
NCT04947865 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04947865 about?
NCT04947865 is a clinical study titled "Reflex Excitability in Post-stroke Stiff-Knee Gait". The purpose of this study is to examine the reflex excitability of the rectus femoris in individuals with and without post-stroke Stiff-Knee gait. We use electrical stimulation of the peripheral nerve innervating the rectus femoris for a well-controlled reflex stimulus. We are investigating whether ...
What is the current status of trial NCT04947865?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-06-11. Estimated completion is 2026-06-11.
What conditions does trial NCT04947865 study?
This clinical trial studies the following conditions: Stroke, Chronic Stroke, Walking, Difficulty, Gait Disorders, Neurologic, Gait, Hemiplegic.
What interventions are being tested in trial NCT04947865?
The interventions under investigation include: Peripheral nerve stimulation (OTHER), Commercial knee brace (DEVICE).
Who is sponsoring clinical trial NCT04947865?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04947865 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04947865's enrollment target sits among peer trials
60 206th of 454 higher than 236 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI